Clinical Trials, FDA, Cancer Corey Hubbard Clinical Trials, FDA, Cancer Corey Hubbard

A New Frontier in Kidney Protection: Understanding the PONTIAK Trial Against Drug-Induced Kidney Damage

Acute kidney injury (AKI) is a serious medical condition that can range from a mild, temporary disruption to severe, permanent damage, potentially leading to the complete failure of the kidneys. This can be a devastating diagnosis, impacting a person's quality of life and potentially requiring intensive medical intervention

Read More